Concise synthesis of xanthones by the tandem etherification—Acylation of diaryliodonium salts with salicylates

Surface modification of chitosan with Ni(II) Schiff base complex: A new heterogeneous catalyst for the synthesis of xanthones

A new biocomposite of chitosan, chitosan-supported di(pyridine-2-yl)methanone-Ni(II) complex, CS-DPM-Ni, is synthesized for the first time. The biocomposite is thoroughly characterized by FTIR, PXRD, XPS, FESEM, EDX, TGA, ICP-OES, and elemental analysis. The synthesized composite is successfully used as a heterogeneous catalyst in the synthesis of a library of xanthone derivatives by the intermolecular catalytical coupling of 2-substituted benzaldehydes and phenols. The catalyst could be retrieved from the reaction mixture by simple filtration and reused for up to four catalytic cycles. All products were isolated in good to high yields (65-90 %) with good turnover numbers (TONs), and fully characterized by 1H and 13C{1H} NMR spectroscopy. The green chemistry metrics values for the reaction were discerned and found to be close to the ideal values.

Diaryliodonium(III) Salts in One-Pot Double Functionalization of C–IIII and ortho C–H Bonds

Since the 1950s, diaryliodonium(III) salts have been demonstrated to participate in various arylation reactions, forming aryl–heteroatom and aryl–carbon bonds. Incorporating the arylation step into sequential transformations would provide access to...

An Update on the Anticancer Activity of Xanthone Derivatives: A Review

The annual number of cancer deaths continues increasing every day; thus, it is urgent to search for and find active, selective, and efficient anticancer drugs as soon as possible. Among the available anticancer drugs, almost all of them contain heterocyclic moiety in their chemical structure. Xanthone is a heterocyclic compound with a dibenzo-γ-pyrone framework and well-known to have "privileged structures" for anticancer activities against several cancer cell lines. The wide anticancer activity of xanthones is produced by caspase activation, RNA binding, DNA cross-linking, as well as P-gp, kinase, aromatase, and topoisomerase inhibition. This anticancer activity depends on the type, number, and position of the attached functional groups in the xanthone skeleton. This review discusses the recent advances in the anticancer activity of xanthone derivatives, both from natural products isolation and synthesis methods, as the anticancer agent through in vitro, in vivo, and clinical assays.

Palladium-Catalyzed Site-Selective Benzocyclization of Naphthoic Acids with Diaryliodonium Salts: Efficient Access to Benzanthrones

Dual activation of both C-I and vicinal C-H bonds of diaryliodonium salts allowing for diarylation is a subject of rapid construction of π-extended frameworks. Here, we report palladium-catalyzed cascade of C₈-arylation/intramolecular Friedel-Crafts acylation of α-naphthoic acids in the synthesis of benzanthrone derivatives. The step-economical protocol tolerates various substrates, which resulted in a potential molecular library for developing functional polycyclic scaffolds. The approach relies on the synergistic action of strong acid with palladium catalysts to form two bonds in a one-pot procedure.

Recent advances in the synthesis of xanthones and azaxanthones

A useful chemical toolbox for (aza)xanthones from 2012 to 2020 that covers the optimization of known procedures and novel methodologies.